Wells Fargo’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8
| Closed | -$810 | – | 7093 |
|
|
2024
Q1 | $810 | Buy |
8
+1
| +14% | +$101 | ﹤0.01% | 5803 |
|
|
2023
Q4 | $157 | Buy |
7
+1
| +17% | +$22 | ﹤0.01% | 6218 |
|
|
2023
Q3 | $127 | Hold |
6
| – | – | ﹤0.01% | 6322 |
|
|
2023
Q2 | $161 | Hold |
6
| – | – | ﹤0.01% | 6451 |
|
|
2023
Q1 | $124 | Hold |
6
| – | – | ﹤0.01% | 6570 |
|
|
2022
Q4 | $119 | Hold |
6
| – | – | ﹤0.01% | 6428 |
|
|
2022
Q3 | $0 | Buy |
6
+1
| +20% | – | ﹤0.01% | 7218 |
|
|
2022
Q2 | $0 | Sell |
5
-594
| -99% | – | ﹤0.01% | 7316 |
|
|
2022
Q1 | $48K | Sell |
599
-268
| -31% | -$21.5K | ﹤0.01% | 5351 |
|
|
2021
Q4 | $176K | Sell |
867
-915
| -51% | -$186K | ﹤0.01% | 4964 |
|
|
2021
Q3 | $576K | Buy |
1,782
+1,457
| +448% | +$471K | ﹤0.01% | 4334 |
|
|
2021
Q2 | $84K | Buy |
325
+137
| +73% | +$35.4K | ﹤0.01% | 5048 |
|
|
2021
Q1 | $72K | Buy |
188
+113
| +151% | +$43.3K | ﹤0.01% | 5294 |
|
|
2020
Q4 | $31K | Buy |
+75
| New | +$31K | ﹤0.01% | 5521 |
|